Cytomegalovirus, a “Friend” of SARS-CoV-2: A Case Report
Abstract
:1. Introduction
2. Case Presentation
2.1. History and Reasons for Admission
2.2. Physical Examination
2.3. Diagnostic Elements and Evaluation
2.4. Therapeutic Management, Monitoring, and Evolution
3. Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Moss, P. “The Ancient and the New”: Is There an Interaction between Cytomegalovirus and SARS-CoV-2 Infection? Immun. Ageing A 2020, 17, 14. [Google Scholar] [CrossRef]
- DeMarchi, J.M.; Blankenship, M.L.; Brown, G.D.; Kaplan, A.S. Size and Complexity of Human Cytomegalovirus DNA. Virology 1978, 89, 643–646. [Google Scholar] [CrossRef] [PubMed]
- Beauvais, D.; Drumez, E.; Blaise, D.; Peffault de Latour, R.; Forcade, E.; Ceballos, P.; Uyttebroeck, A.; Labussière, H.; Nguyen, S.; Bourhis, J.-H.; et al. Scoring System for Clinically Significant CMV Infection in Seropositive Recipients Following Allogenic Hematopoietic Cell Transplant: An SFGM-TC Study. Bone Marrow Transplant. 2021, 56, 1305–1315. [Google Scholar] [CrossRef]
- Lichtner, M.; Cicconi, P.; Vita, S.; Cozzi-Lepri, A.; Galli, M.; Lo Caputo, S.; Saracino, A.; De Luca, A.; Moioli, M.; Maggiolo, F.; et al. Cytomegalovirus Coinfection Is Associated with an Increased Risk of Severe Non-AIDS-Defining Events in a Large Cohort of HIV-Infected Patients. J. Infect. Dis. 2015, 211, 178–186. [Google Scholar] [CrossRef] [PubMed]
- Yeh, P.-J.; Wu, R.-C.; Chen, C.-L.; Chiu, C.-T.; Lai, M.-W.; Chen, C.-C.; Chiu, C.-H.; Pan, Y.-B.; Lin, W.-R.; Le, P.-H. Cytomegalovirus Diseases of the Gastrointestinal Tract in Immunocompetent Patients: A Narrative Review. Viruses 2024, 16, 346. [Google Scholar] [CrossRef]
- Lischka, P.; Zimmermann, H. Antiviral Strategies to Combat Cytomegalovirus Infections in Transplant Recipients. Curr. Opin. Pharmacol. 2008, 8, 541–548. [Google Scholar] [CrossRef] [PubMed]
- Wagstaff, A.J.; Bryson, H.M. Foscarnet. A Reappraisal of Its Antiviral Activity, Pharmacokinetic Properties and Therapeutic Use in Immunocompromised Patients with Viral Infections. Drugs 1994, 48, 199–226. [Google Scholar] [CrossRef] [PubMed]
- Chou, S.; Marousek, G.I.; Van Wechel, L.C.; Li, S.; Weinberg, A. Growth and Drug Resistance Phenotypes Resulting from Cytomegalovirus DNA Polymerase Region III Mutations Observed in Clinical Specimens. Antimicrob. Agents Chemother. 2007, 51, 4160–4162. [Google Scholar] [CrossRef]
- Consiglio, C.R.; Cotugno, N.; Sardh, F.; Pou, C.; Amodio, D.; Rodriguez, L.; Tan, Z.; Zicari, S.; Ruggiero, A.; Pascucci, G.R.; et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell 2020, 183, 968–981.e7. [Google Scholar] [CrossRef]
- Bouhaddou, M.; Memon, D.; Meyer, B.; White, K.M.; Rezelj, V.V.; Correa Marrero, M.; Polacco, B.J.; Melnyk, J.E.; Ulferts, S.; Kaake, R.M.; et al. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell 2020, 182, 685–712.e19. [Google Scholar] [CrossRef] [PubMed]
- Brodin, P. Why Is COVID-19 so Mild in Children? Acta Paediatr. 2020, 109, 1082–1083. [Google Scholar] [CrossRef] [PubMed]
- Lacina, L.; Brábek, J.; Fingerhutová, Š.; Zeman, J.; Smetana, K. Pediatric Inflammatory Multisystem Syndrome (PIMS)—Potential Role for Cytokines Such Is IL-6. Physiol. Res. 2021, 70, 153–159. [Google Scholar] [CrossRef]
- Calò Carducci, F.I.; De Ioris, M.A.; Agrati, C.; Carsetti, R.; Perrotta, D.; D’Argenio, P.; De Benedetti, F.; Notari, S.; Rossi, P.; Campana, A. Hyperinflammation in Two Severe Acute Respiratory Syndrome Coronavirus 2-Infected Adolescents Successfully Treated With the Interleukin-1 Inhibitor Anakinra and Glucocorticoids. Front. Pediatr. 2020, 8, 576912. [Google Scholar] [CrossRef]
- Paediatric Multisystem Inflammatory Syndrome Temporally Associated with COVID-19 (PIMS)—Guidance for Clinicians. Available online: https://www.rcpch.ac.uk/resources/paediatric-multisystem-inflammatory-syndrome-temporally-associated-covid-19-pims-guidance (accessed on 7 March 2021).
- HAN Archive—00432|Health Alert Network (HAN). Available online: https://archive.cdc.gov/emergency_cdc_gov/han/2020/han00432.asp (accessed on 21 July 2024).
- World Health Organization. Multisystem Inflammatory Syndrome in Children and Adolescents with COVID-19; Scientific Brief; World Health Organization: Geneva, Switzerland, 2020. [Google Scholar]
- Harwood, R.; Allin, B.; Jones, C.E.; Whittaker, E.; Ramnarayan, P.; Ramanan, A.V.; Kaleem, M.; Tulloh, R.; Peters, M.J.; Almond, S.; et al. A National Consensus Management Pathway for Paediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19 (PIMS-TS): Results of a National Delphi Process. Lancet Child Adolesc. Health 2021, 5, 133–141. [Google Scholar] [CrossRef]
- Henderson, L.A.; Canna, S.W.; Friedman, K.G.; Gorelik, M.; Lapidus, S.K.; Bassiri, H.; Behrens, E.M.; Ferris, A.; Kernan, K.F.; Schulert, G.S.; et al. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2. Arthritis Rheumatol. 2021, 73, e13–e29. [Google Scholar] [CrossRef] [PubMed]
- Del Borrello, G.; Giraudo, I.; Bondone, C.; Denina, M.; Garazzino, S.; Linari, C.; Mignone, F.; Pruccoli, G.; Scolfaro, C.; Spadea, M.; et al. SARS-CoV-2-Associated Coagulopathy and Thromboembolism Prophylaxis in Children: A Single-Center Observational Study. J. Thromb. Haemost. JTH 2021, 19, 522–530. [Google Scholar] [CrossRef]
- Chakravarty, S.D.; Zabriskie, J.B.; Gibofsky, A. Acute Rheumatic Fever and Streptococci: The Quintessential Pathogenic Trigger of Autoimmunity. Clin. Rheumatol. 2014, 33, 893–901. [Google Scholar] [CrossRef]
- Yavuz, L.; AlHamdani, S.; Alasrawi, S.; Wafadari, D.; Al-Fraihat, A.; Bebars, M.A.; Nath, J.; Arango, D.; Pallavidino, M.; Jain, R.; et al. Kawasaki Disease (KD) and Multisystem Inflammatory Syndrome in Children (MIS-C) in a Middle Eastern Patient Cohort. Pediatr. Rheumatol. Online J. 2023, 21, 64. [Google Scholar] [CrossRef]
- Franceschini, E.; Cozzi-Lepri, A.; Santoro, A.; Bacca, E.; Lancellotti, G.; Menozzi, M.; Gennari, W.; Meschiari, M.; Bedini, A.; Orlando, G.; et al. Herpes Simplex Virus Re-Activation in Patients with SARS-CoV-2 Pneumonia: A Prospective, Observational Study. Microorganisms 2021, 9, 1896. [Google Scholar] [CrossRef] [PubMed]
- Zuhair, M.; Smit, G.S.A.; Wallis, G.; Jabbar, F.; Smith, C.; Devleesschauwer, B.; Griffiths, P. Estimation of the Worldwide Seroprevalence of Cytomegalovirus: A Systematic Review and Meta-Analysis. Rev. Med. Virol. 2019, 29, e2034. [Google Scholar] [CrossRef]
- Algaadi, S.A. Herpes Zoster and COVID-19 Infection: A Coincidence or a Causal Relationship? Infection 2022, 50, 289–293. [Google Scholar] [CrossRef] [PubMed]
- Chen, T.; Song, J.; Liu, H.; Zheng, H.; Chen, C. Positive Epstein-Barr Virus Detection in Coronavirus Disease 2019 (COVID-19) Patients. Sci. Rep. 2021, 11, 10902. [Google Scholar] [CrossRef] [PubMed]
- Xie, Y.; Cao, S.; Dong, H.; Lv, H.; Teng, X.; Zhang, J.; Wang, T.; Zhang, X.; Qin, Y.; Chai, Y.; et al. Clinical Characteristics and Outcomes of Critically Ill Patients with Acute COVID-19 with Epstein-Barr Virus Reactivation. BMC Infect. Dis. 2021, 21, 955. [Google Scholar] [CrossRef]
- Mandelia, Y.; Procop, G.W.; Richter, S.S.; Worley, S.; Liu, W.; Esper, F. Dynamics and Predisposition of Respiratory Viral Co-Infections in Children and Adults. Clin. Microbiol. Infect. Off. Publ. Eur. Soc. Clin. Microbiol. Infect. Dis. 2021, 27, 631.e1–631.e6. [Google Scholar] [CrossRef]
- Kim, D.; Quinn, J.; Pinsky, B.; Shah, N.H.; Brown, I. Rates of Co-Infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA 2020, 323, 2085–2086. [Google Scholar] [CrossRef]
- Wu, Q.; Xing, Y.; Shi, L.; Li, W.; Gao, Y.; Pan, S.; Wang, Y.; Wang, W.; Xing, Q. Coinfection and Other Clinical Characteristics of COVID-19 in Children. Pediatrics 2020, 146, e20200961. [Google Scholar] [CrossRef]
- Cannon, M.J.; Schmid, D.S.; Hyde, T.B. Review of Cytomegalovirus Seroprevalence and Demographic Characteristics Associated with Infection. Rev. Med. Virol. 2010, 20, 202–213. [Google Scholar] [CrossRef] [PubMed]
- Staras, S.A.S.; Dollard, S.C.; Radford, K.W.; Flanders, W.D.; Pass, R.F.; Cannon, M.J. Seroprevalence of Cytomegalovirus Infection in the United States, 1988–1994. Clin. Infect. Dis. 2006, 43, 1143–1151. [Google Scholar] [CrossRef]
- Korndewal, M.J.; Mollema, L.; Tcherniaeva, I.; van der Klis, F.; Kroes, A.C.M.; Oudesluys-Murphy, A.M.; Vossen, A.C.T.M.; de Melker, H.E. Cytomegalovirus Infection in the Netherlands: Seroprevalence, Risk Factors, and Implications. J. Clin. Virol. 2015, 63, 53–58. [Google Scholar] [CrossRef]
- Klenerman, P.; Oxenius, A. T Cell Responses to Cytomegalovirus. Nat. Rev. Immunol. 2016, 16, 367–377. [Google Scholar] [CrossRef]
- Stowe, R.P.; Kozlova, E.V.; Yetman, D.L.; Walling, D.M.; Goodwin, J.S.; Glaser, R. Chronic Herpesvirus Reactivation Occurs in Aging. Exp. Gerontol. 2007, 42, 563–570. [Google Scholar] [CrossRef] [PubMed]
- Parry, H.M.; Zuo, J.; Frumento, G.; Mirajkar, N.; Inman, C.; Edwards, E.; Griffiths, M.; Pratt, G.; Moss, P. Cytomegalovirus Viral Load within Blood Increases Markedly in Healthy People over the Age of 70 Years. Immun. Ageing A 2016, 13, 1. [Google Scholar] [CrossRef]
- Weimer, K.; Permar, S. When and How to Treat Neonatal CMV Infection. Infect. Dis. Pharmacol. 2019, 2019, 27–36. [Google Scholar] [CrossRef]
- Styczynski, J. Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation. Infect. Dis. Ther. 2018, 7, 1–16. [Google Scholar] [CrossRef]
- Govender, K.; Jeena, P.; Parboosing, R. Clinical Utility of Bronchoalveolar Lavage Cytomegalovirus Viral Loads in the Diagnosis of Cytomegalovirus Pneumonitis in Infants. J. Med. Virol. 2017, 89, 1080–1087. [Google Scholar] [CrossRef]
- Cuadrado, M.M.; Ahmed, A.; Carpenter, B.; Brown, J.S. Cytomegalovirus Pneumonitis Complicated by a Central Peribronchial Pattern of Organising Pneumonia. Respir. Med. Case Rep. 2017, 20, 184–187. [Google Scholar] [CrossRef] [PubMed]
- Jiang, W.; Chen, S.; Xu, L.; Xu, X.; Huang, L.; Wang, Y.; Hao, C. Presence of Cytomegalovirus Infection Is Associated With an Unfavorable Outcome in Immunocompetent Infants With Pertussis. Front. Cell. Infect. Microbiol. 2022, 12, 800452. [Google Scholar] [CrossRef]
- Sue, P.K.; Salazar-Austin, N.M.; McDonald, O.G.; Rishi, A.; Cornish, T.C.; Arav-Boger, R. Cytomegalovirus Enterocolitis in Immunocompetent Young Children: A Report of Two Cases and Review of the Literature. Pediatr. Infect. Dis. J. 2016, 35, 573–576. [Google Scholar] [CrossRef]
- Doan, T.T.M.; Phung, T.T.B.; Pham, H.V.; Pham, S.H.; Nguyen, L.T. Effect of Ganciclovir for the Treatment of Severe Cytomegalovirus-Associated Pneumonia in Children without a Specific Immunocompromised State. BMC Infect. Dis. 2013, 13, 424. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Tomşa, N.-A.; Meliţ, L.E.; Bucur, G.; Văsieșiu, A.-M.; Mărginean, C.O. Cytomegalovirus, a “Friend” of SARS-CoV-2: A Case Report. Children 2024, 11, 1010. https://doi.org/10.3390/children11081010
Tomşa N-A, Meliţ LE, Bucur G, Văsieșiu A-M, Mărginean CO. Cytomegalovirus, a “Friend” of SARS-CoV-2: A Case Report. Children. 2024; 11(8):1010. https://doi.org/10.3390/children11081010
Chicago/Turabian StyleTomşa, Nicoleta-Ana, Lorena Elena Meliţ, Gabriela Bucur, Anca-Meda Văsieșiu, and Cristina Oana Mărginean. 2024. "Cytomegalovirus, a “Friend” of SARS-CoV-2: A Case Report" Children 11, no. 8: 1010. https://doi.org/10.3390/children11081010